Radiation and new molecular agents part I: Targeting ATM-ATR checkpoints, DNA repair, and the proteasome

Seminars in Radiation Oncology

Volumn 16, Issue 1, 2006, Pages 51-58

  Choudhury, Ananya ^a   Cuddihy, Andrew ^a   Bristow, Robert G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 DIMETHYLAMINOPROPYLAMINO) 2 (4 METHOXYSTYRYL)QUINAZOLINE; 7 HYDROXYSTAUROSPORINE; 8 HYDROXY 2 METHYL 4(3H) QUINAZOLINONE; ADENOVIRUS VECTOR; AG 14361; ATM PROTEIN; ATR PROTEIN; BORTEZOMIB; CAMPTOTHECIN; CEP 3891; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; FLAVOPIRIDOL; IC 88621; KU 0058684; KU 55933; N [5 (5 TERT BUTYL 2 OXAZOLYLMETHYLTHIO) 2 THIAZOLYL]ISONIPECOTAMIDE; NU 7026; NU 7163; NU 7441; ONYX 015; PENTOXIFYLLINE; PHOSPHOTRANSFERASE INHIBITOR; PIFITHRIN ALPHA; PROTEASOME; PROTEIN KINASE INHIBITOR; PROTEIN P53; RAD51 PROTEIN; RADIOSENSITIZING AGENT; RITONAVIR; ROSCOVITINE; SAQUINAVIR; SMALL INTERFERING RNA; STAUROSPORINE; SU 1172; SU 11752; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CLINICAL TRIAL; CORRELATION ANALYSIS; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; GENE SILENCING; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPOXEMIA; NAUSEA AND VOMITING; NON HOMOLOGOUS END JOINING; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN TARGETING; RADIATION DOSE FRACTIONATION; RADIOSENSITIZATION; REVIEW; RNA INTERFERENCE; SYNCOPE; TUMOR CELL; VIRAL GENE THERAPY;

EID: 29244484430     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2005.08.007     Document Type: Article

References (48)

1. O. Faulhaber, R.G. Bristow Basis of cell kill following clinical radiotherapy, in Sluyser, Mels (eds) Application of Apoptosis to Cancer Treatment 2005 Springer Publishing Dordrecht, The Netherlands
2. R.G. Bristow, L. Harrington Genetic instability and DNA repair I.F.H.R. Tannock L. Harrington R.G. Bristow The Basic Science of Oncology 4th ed. 2005 McGraw-Hill Ltd New York 77 99
3. C.P. Diggle, J. Bentley, M.A. Knowles Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts Nucleic Acids Res 33 2005 2531 2539
4. F.M. Wachters, J.W. van Putten, J.G. Maring Selective targeting of homologous DNA recombination repair by gemcitabine Int J Radiat Oncol Biol Phys 57 2003 553 562
5. J. Lukas, C. Lukas, J. Bartek Mammalian cell cycle checkpoints signalling pathways and their organization in space and time DNA Repair (Amst) 3 2004 997 1007
6. P.S. Bradshaw, D.J. Stavropoulos, M.S. Meyn Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage Nat Genet 37 2005 193 197
7. A.R. Cuddihy, R.G. Bristow The p53 protein family and radiation sensitivity Yes or no? Cancer Metastasis Rev 23 2004 237 257
8. G.D. Wilson Radiation and the cell cycle, revisited Cancer Metastasis Rev 23 2004 209 225
9. A. Sullivan, N. Syed, M. Gasco Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo Oncogene 23 2004 3328 3337
10. A. Eastman Cell cycle checkpoints and their impact on anticancer therapeutic strategies J Cell Biochem 91 2004 223 231
11. S.J. Collis, M.J. Swartz, W.G. Nelson Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors Cancer Res 63 2003 1550 1554
12. I. Hickson, Y. Zhao, C.J. Richardson Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM Cancer Res 64 2004 9152 9159
13. S.G. Swisher, J.A. Roth, R. Komaki Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy Clin Cancer Res 9 2003 93 101
14. O. Wildner Clinical trials The sensitizing side of Onyx-015 Gene Ther 12 2005 386 387
15. P.G. Komarov, E.A. Komarova, R.V. Kondratov A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy Science 285 1999 1733 1737
16. T. Kawabe G2 checkpoint abrogators as anticancer drugs Mol Cancer Ther 3 2004 513 519
17. M.E. Noble, J.A. Endicott, L.N. Johnson Protein kinase inhibitors Insights into drug design from structure Science 303 2004 1800 1805
18. H.H. Xiao, Y. Makeyev, J. Butler 7-Hydroxystaurosporine (UCN-01) preferentially sensitizes cells with a disrupted TP53 to gamma radiation in lung cancer cell lines Radiat Res 158 2002 84 93
19. R.G. Syljuasen, C.S. Sorensen, L.T. Hansen Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage Mol Cell Biol 25 2005 3553 3562
20. U.K. Mukhopadhyay, A.M. Senderowicz, G. Ferbeyre RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells Cancer Res 65 2005 2872 2881
21. E. Tsuchida, M. Urano The effect of UCN-01 (7-hydroxystaurosporine), a potent inhibitor of protein kinase C, on fractionated radiotherapy or daily chemotherapy of a murine fibrosarcoma Int J Radiat Oncol Biol Phys 39 1997 1153 1161
22. K. Bishay, K. Ory, M.F. Olivier DNA damage-related RNA expression to assess individual sensitivity to ionizing radiation Carcinogenesis 22 2001 1179 1183
23. C. Djuzenova, B. Muhl, R. Schakowski Normal expression of DNA repair proteins, hMre11, Rad50 and Rad51 but protracted formation of Rad50 containing foci in X-irradiated skin fibroblasts from radiosensitive cancer patients Br J Cancer 90 2004 2356 2363
24. R. Fan, T.S. Kumaravel, F. Jalali Defective DNA strand break repair after DNA damage in prostate cancer cells implications for genetic instability and prostate cancer progression Cancer Res 64 2004 8526 8533
25. N. Taneja, M. Davis, J.S. Choy Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy J Biol Chem 279 2004 2273 2280
26. C. Wyman, D. Ristic, R. Kanaar Homologous recombination-mediated double-strand break repair DNA Repair (Amst) 3 2004 827 833
27. E. Raderschall, K. Stout, S. Freier Elevated levels of Rad51 recombination protein in tumor cells Cancer Res 62 2002 219 225
28. H. Farmer, N. McCabe, C.J. Lord Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature 434 2005 917 921
29. S.J. Collis, A. Tighe, S.D. Scott Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells Nucleic Acids Res 29 2001 1534 1538
30. J.S. Russell, K. Brady, W.E. Burgan Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity Cancer Res 63 2003 7377 7383
31. A. Slupianek, C. Schmutte, G. Tombline BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance Mol Cell 8 2001 795 806
32. V.A. Soldatenkov, V.N. Potaman DNA-binding properties of poly(ADP-ribose) polymerase a target for anticancer therapy Curr Drug Targets 5 2004 357 365
33. H.E. Bryant, N. Schultz, H.D. Thomas Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Nature 434 2005 913 917
34. E. Weterings, D.C. van Gent The mechanism of non-homologous end-joining A synopsis of synapsis DNA Repair 3 2004 1425 1435
35. E. Riballo, M. Kuhne, N. Rief A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci Mol Cell 16 2004 715 724
36. Y. Peng, R.G. Woods, H. Beamish Deficiency in the catalytic subunit of DNA-dependent protein kinase causes down-regulation of ATM Cancer Res 65 2005 1670 1677
37. S. Durant, P. Karran Vanillins - A novel family of DNA-PK inhibitors Nucleic Acids Res 31 2003 5501 5512
38. E. Willmore, S. de Caux, N.J. Sunter A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia Blood 103 2004 4659-4565
39. S.J. Veuger, N.J. Curtin, C.J. Richardson Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1 Cancer Res 63 2003 6008 6115
40. J.P. Banath, S.H. Macphail, P.L. Olive Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines Cancer Res 64 2004 7144 7149
41. W.H. McBride, K.S. Iwamoto, R. Syljuasen The role of the ubiquitin/proteasome system in cellular responses to radiation Oncogene 22 2003 5755 5773
42. N.J. Krogan, M.H. Lam, J. Fillingham Proteasome involvement in the repair of DNA double-strand breaks Mol Cell 16 2004 1027 1034
43. J.F. Kurland, R.E. Meyn Protease inhibitors restore radiation-induced apoptosis to Bcl-2-expressing lymphoma cells Int J Cancer 96 2001 327 333
44. B.A. Teicher, G. Ara, R. Herbst The proteasome inhibitor PS-341 in cancer therapy Clin Cancer Res 5 1999 2638 2645
45. F. Pajonk, J. Himmelsbach, K. Riess The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells Cancer Res 62 2002 5230 5235
46. J. Bartkova, Z. Horejsi, K. Koed DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Nature 434 2005 864 870
47. O.F. Qvarnstrom, M. Simonsson, K.A. Johansson DNA double strand break quantification in skin biopsies Radiother Oncol 72 2004 311 317
48. B.B. Ma, R.G. Bristow, J. Kim Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents J Clin Oncol 21 2003 2760 2776